Ligand Pharmaceuticals
LGND
#3601
Rank
$3.63 B
Marketcap
$184.87
Share price
-1.93%
Change (1 day)
48.10%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): $66.79 Million USD

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are $0.25 Billion USD. In 2024 the company made an earning of $5.55 Million USD a decrease over its 2023 earnings that were of $64.31 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $66.79 M1103.26%
2024 $5.55 M-91.37%
2023 $64.31 M-7.59%
2022 $69.6 M4%
2021 $66.92 M296.42%
2020 $16.88 M-97.97%
2019 $0.83 B275.62%
2018 $0.22 B237.48%
2017 $65.66 M49.05%
2016 $44.05 M55.41%
2015 $28.34 M36.87%
2014 $20.71 M29.59%
2013 $15.98 M1309.35%
2012 $1.13 M-43.97%
2011 $2.02 M-113.19%
2010 -$15.35 Million59.86%
2009 -$9.6 Million-61.33%
2008 -$24.83 Million-58.75%
2007 -$60.18 Million20.52%
2006 -$49.93 Million81.27%
2005 -$27.55 Million
2003 -$19.18 Million-20.6%
2002 -$24.16 Million4.38%
2001 -$23.14 Million-48.83%
2000 -$45.22 Million-19.74%
1999 -$56.34 Million-19.06%
1998 -$69.6 Million126.71%
1997 -$30.7 Million-5.83%
1996 -$32.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
$8.24 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-$61.89 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$9.32 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$23.09 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-$0.27 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA